prof. dr. Peter Vandenabeele

Journal Article
A1
open access

Cell death in cancer

Marcus Conrad, Andreas Strasser, Philipp J Jost, Junying Yuan, Feng Shao, Peter Vandenabeele (UGent) and Adam Wahida (UGent)

(2026) CELL. 189(8). p.2322-2356

Add to list

Journal Article
A1
open access

Caspase-3/7 deficiency results in enhanced intestinal inflammation and reduced tumorigenesis

Wei Xie (UGent) , Laura Wyckaert (UGent) , Mike Vadi (UGent) , Bruno Verstraeten (UGent) , Tatyana Divert (UGent) , Jef Haerinck (UGent) , Riet De Rycke (UGent) , Femke Baeke (UGent) , Mohamed Lamkanfi (UGent) , Geert Berx (UGent) , et al.

(2026) SCIENCE ADVANCES. 12(12).

Add to list

Journal Article
A1
open access

TAB2 controls a TAK1-independent cell death checkpoint at the level of TNFR1 complex II in the TNF pathway

Tom Delanghe (UGent) , Mike Vadi (UGent) , Annelore Haems (UGent) , Lisa Wijns, Inge Bruggeman (UGent) , Jon Huyghe (UGent) , Dario Priem (UGent) , Peter Vandenabeele (UGent) and Mathieu Bertrand (UGent)

(2026) CELL DEATH AND DIFFERENTIATION. 33(1). p.64-76

Add to list

Journal Article
A1
open access

Ripk1 is critical for preserving effector regulatory T cells and the suppressive transcriptional program in regulatory T cells

Carlos Plaza-Sirvent, Hannah Sturm, Maximilian K. Nocke, Fatemeh Ghorbani, Clara Bessen, Marina C. Greweling-Pils, Stefan Floess, Jana Niemz, Jelle Huysentruyt, Peter Tougaard (UGent) , et al.

(2026) CELL DEATH AND DIFFERENTIATION. 33. p.284-297

Add to list

Book Chapter
open access

For better or worse : the impact of necrotic cell death modalities

Peter Vandenabeele (UGent) , Marcus Conrad and Adam Wahida (UGent)

(2025) Apoptosis and other forms of cell death in the regulation of inflammation in health and disease. In Advances in experimental medicine and biology 1481. p.241-292

Add to list

Journal Article
A1
open access

ATG9A-mediated autophagy prevents inflammatory skin disease by limiting TNFR1-driven STING activation and ZBP1-dependent cell death

Dario Priem (UGent) , Jon Huyghe (UGent) , Barbara Gilbert (UGent) , Simon Verdonck (UGent) , Tom Delanghe (UGent) , Bruno Verstraeten (UGent) , Esther Hoste (UGent) , Peter Vandenabeele (UGent) , Jonathan Maelfait (UGent) , Geert van Loo (UGent) , et al.

(2025) IMMUNITY. 58(12). p.2972-2988.e6

Add to list

Journal Article
A1
open access

Development and validation of a high-throughput screening pipeline of compound libraries to target EMT

Sven Jonckheere, Joachim Taminau (UGent) , Jamie Adams, Jef Haerinck (UGent) , Jordy De Coninck (UGent) , Jeroen Verstappe (UGent) , Kato De Clercq (UGent) , Evelien Peeters (UGent) , Alexander Gheldof (UGent) , Eva De Smedt (UGent) , et al.

(2025) CELL DEATH AND DIFFERENTIATION. 32(11). p.2078-2092

Add to list

Journal Article
A1
open access

RIPK1 ablation in T cells results in spontaneous enteropathy and TNF-driven villus atrophy

Jelle Huysentruyt, Wolf Steels, Mario Ruiz Pérez, Bruno Verstraeten (UGent) , Tatyana Divert (UGent) , Kayleigh Flies, Kelly Lemeire (UGent) , Nozomi Takahashi (UGent) , Elke De Bruyn (UGent) , Marie Joossens (UGent) , et al.

(2025) EMBO REPORTS. 26(10). p.2654-2682

Add to list

Journal Article
A1
open access

Macrophage caspase-8 inhibition accelerates necrotic core expansion in atheroma plaque in mice

Thomas Pilot, Stéphanie Solier, Antoine Jalil, Charlène Magnani, Tom Vanden Berghe (UGent) , Peter Vandenabeele (UGent) , David Masson, Eric Solary and Charles Thomas

(2025) FRONTIERS IN IMMUNOLOGY. 16.

Add to list

Journal Article
A1
open access

Enhancing anti-tumor immunity through intratumoral combination therapy with amphiphilic conjugates of oxaliplatin and imidazoquinoline TLR7/8 agonist

Hanne Verschuere (UGent) , Sabah Kasmi (UGent) , Lutz Nuhn (UGent) , Sènan Mickaël D'Almeida, Qiwen Zhu, Zifu Zhong (UGent) , Sandy Adjemian Catani (UGent) , Benoit Louage (UGent) , Jana De Vrieze, Haijun Yu, et al.

(2025) RSC ADVANCES. 15(15). p.11662-11674

Academic Bibliography

prof. dr. Peter Vandenabeele

Cell death in cancer

Caspase-3/7 deficiency results in enhanced intestinal inflammation and reduced tumorigenesis

TAB2 controls a TAK1-independent cell death checkpoint at the level of TNFR1 complex II in the TNF pathway

Ripk1 is critical for preserving effector regulatory T cells and the suppressive transcriptional program in regulatory T cells

For better or worse : the impact of necrotic cell death modalities

ATG9A-mediated autophagy prevents inflammatory skin disease by limiting TNFR1-driven STING activation and ZBP1-dependent cell death

Development and validation of a high-throughput screening pipeline of compound libraries to target EMT

RIPK1 ablation in T cells results in spontaneous enteropathy and TNF-driven villus atrophy

Macrophage caspase-8 inhibition accelerates necrotic core expansion in atheroma plaque in mice

Enhancing anti-tumor immunity through intratumoral combination therapy with amphiphilic conjugates of oxaliplatin and imidazoquinoline TLR7/8 agonist

Contents

Support

Contact